Ibio Inc (NYSE American:IBIO)

1.93
Delayed Data
As of Oct 23
 -0.055 / -2.78%
Today’s Change
0.05
Today|||52-Week Range
7.45
+673.09%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$369.6M

Company Description

iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. The firm operates through the iBio, Inc. and iBio CDMO business segments. The company was founded by Robert B. Kay on April 15, 1993 and is headquartered in Bryan, TX.

Contact Information

iBio, Inc.
8800 HSC Parkway
Bryan Texas 77807-1107
P:(302) 355-0650
Investor Relations:
(646) 274-3580

Employees

Shareholders

Individual stakeholders4.49%
Mutual fund holders4.02%
Other institutional2.57%

Top Executives

Thomas F. IsettExecutive Chairman & Chief Executive Officer
Robert L. ErwinPresident
John DeltaChief Financial & Accounting Officer
James AbbeyVice President-Strategic Business Development
Stephen KilmerInvestor Relations Contact